Results 231 to 240 of about 318,932 (267)
Some of the next articles are maybe not open access.

Angioimmunoblastic T-Cell Lymphoma

2018
Angioimmunoblastic T-cell lymphoma (AITL) is one of the most common types of T-cell lymphoma, representing about 15-20% of cases of peripheral T-cell lymphoma (PTCL). It is characterized by a unique clinical presentation and distinct pathologic and molecular features.
Mariko, Yabe   +3 more
openaire   +2 more sources

Peripheral T-cell lymphoma

Cancer and Metastasis Reviews, 1988
Since the discovery of human T-cell leukemia virus type 1 (HTLV-1) in patients with adult T-cell leukemia/lymphoma (ATLL), malignant neoplasms of mature (peripheral) T lymphocytes have attracted a great deal of attention. This type of neoplasm is more common in Japan than in Western countries, and may show distinct clinical pictures such as ...
S, Watanabe, K, Mukai, M, Shimoyama
openaire   +2 more sources

Hepatosplenic T-Cell Lymphomas

2018
Hepatosplenic T-cell lymphoma (HSTL) is a rare variant of extranodal peripheral T-cell lymphomas (PTCL), associated with aggressive disease course and a relentless track record for lethal outcomes. HSTL presents commonly in young men in their third or fourth decade.
Lohith, Gowda, Francine, Foss
openaire   +2 more sources

Angioimmunoblastic T-Cell Lymphoma

Hematology/Oncology Clinics of North America, 2017
Angioimmunoblastic T-cell lymphoma is a follicular T-helper-derived neoplasm displaying a peculiar morphologic appearance and biological complexity. New mutations have been described that contribute to elucidating the underlying pathogenetic events. The disease behaves aggressively and typically affects elderly patients.
BROCCOLI, ALESSANDRO   +1 more
openaire   +2 more sources

Cutaneous T Cell Lymphoma

Medical Clinics of North America, 1982
Cutaneous T cell lymphoma is a malignancy of helper T cells, which have a propensity to infiltrate the skin. The incidence of the disease appears to exceed that of Hodgkin's disease, making it the most common lymphoma of adults. Advances in our knowledge of the biology of the malignant T cells should facilitate new and more effective forms of treatment.
J A, Patterson, R L, Edelson
openaire   +2 more sources

Rare T-Cell Lymphomas

2007
The evolving classification systems in lymphoma have been driven by advances in the pathologic characterization of lymphoid malignancies. As evidenced by the detailed pathology descriptions earlier, subdividing heterogenous diseases results in an increasing number of distinct subtypes.
Ana Maria, Molina, Steven M, Horwitz
openaire   +2 more sources

Peripheral T-Cell Lymphomas

Hematology/Oncology Clinics of North America, 2009
Peripheral T-cell lymphomas (PTCLs) are malignancies of immunologically mature T-cells that arise in peripheral lymphoid tissues such as lymph nodes, spleen, gastrointestinal tract, and skin. These lymphomas are uncommon as compared with the incidence of B-cell lymphomas, and they comprise only 5% to 10% of non-Hodgkin lymphomas in North America and ...
openaire   +2 more sources

Peripheral T-cell Lymphomas

Blood Reviews, 2007
Peripheral T-cell lymphomas (PTCLs) are a biologically diverse and uncommon group of diseases. Compared to their B-cell counterparts, PTCLs remain largely unexplored and the optimal treatment ill-defined due to disease rarity and biological heterogeneity. With the notable exception of ALK-pos anaplastic large cell lymphoma (ALCL), the prognosis of most
openaire   +2 more sources

T-cell lymphoma

Best Practice & Research Clinical Haematology, 2013
Catherine, Lai, Wyndham, Wilson
openaire   +2 more sources

Cutaneous T-cell lymphoma

Seminars in Oncology Nursing, 1991
I N 1806, FRENCH dermatologist Baron Jean Louis Alibert’ identified the unique characteristics of the disease process known today as cutaneous T-cell lymphoma (CTCL). He called it “mycosis fungoides” (MF), not because it was a fungus, but because of the mushroom-like nature of the cutaneous lesions found in the advanced stages of the disease.
openaire   +2 more sources

Home - About - Disclaimer - Privacy